Rhonda Patrick· PhD
There are small clinical studies that show that oral nicotenomide riocide improves cerebral blood flow in people with mild cognitive impairment.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
There are small clinical studies that show that oral nicotenomide riocide improves cerebral blood flow in people with mild cognitive impairment.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
So that's I think I'm I'm on at least one paper on mild cognitive impairment where nicotenoid ribocide is beginning to show some you know important signs like improving cerebral blood flow you know in this population.